References
- Bestor, T. H. and V. M. Ingram. 1983. Two DNA methyltransferases from murine erythroleukemia cells: purification, sequence specificity, and mode of interaction with DNA. Proc. Natl. Acad. Sci. USA 80, 5559-5563 https://doi.org/10.1073/pnas.80.18.5559
- Chim, C. S., R. Liang, C. Y. Tam and Y. L. Kwong. 2001. Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance. J. Clin. Oncol. 19, 2033-2040 https://doi.org/10.1200/JCO.2001.19.7.2033
- Costello, J. F., M. C. Fruhwald, D. J. Smiragilia, L. J. Rush, G. P. Robertson, X. Gao, F. A. Wright, J. D. Feramisoco, P. Peltomaki, J. C. Lang, D. E. Schuller, L. Yu, C. D. Bloomfield, M. A. Caligiuri, A. Yates, R. Nishikawa, H. Su Hwang, N. J. Petrelli, X. Zhang, M. S. O'Dorisio, W. A. Held, W. K. Cavenee and C. Plass. 2000. Aberrant CpG-island methylaiton has non-random and tumour-type-specific patterns. Nat. Genet. 25, 132-138 https://doi.org/10.1038/75957
- Esteller, M., P. G. Corn, S. B. Baylin and J. G. Herman. 2001. A gene hypermethylation profile of human cancer. Cancer Res. 61, 3225-3229
- Esteller, M. 2002. CpG island hypomethylation and tumor suppressor genes: a booming present, a bright future. Oncogene 21, 5427-5440 https://doi.org/10.1038/sj.onc.1205600
- Esteller, M. and J. G. Herman. 2002. Cancer as an epigenetic disease: DNA methylaiton and chromatin alterations in human tumours. J. Pathol. 196, 1-7 https://doi.org/10.1002/path.1024
- Fang, M. Z., Y. Wang, N. Ai, Z. Hou, Y. Sun, H. Lu, W. Welsh and C. S. Yang. 2003.Tea polyphenol (-)-epigallo-catechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 63, 7563-7570
- Fraga, M. F., E. Ballestar, G. Montoya, P. Taysavang, P. A. Wade and M. Esteller. 2003. The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res. 31, 1765-1774 https://doi.org/10.1093/nar/gkg249
- Herman J. G. and S. B. Baylin. 2003. Gene silencing in cancer in association with promoter hyperrnethylaiton. N. Engl. J. Med. 349, 2042-2054 https://doi.org/10.1056/NEJMra023075
- Hu, C. X., I. H. Wong and L. W. Chow. 2003. Tumor--derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications. Oncol. Rep. 10, 1811-1815
- Kass, S. U., D. Pruss and A. P. Wolffe. 1997. How does DNA methylation repress transcription? Trends Genet. 13, 444-449 https://doi.org/10.1016/S0168-9525(97)01268-7
- Koh, J., G. H. Enders, B. D. Dynlacht and E. Harlow. 1995. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375, 506-510 https://doi.org/10.1038/375506a0
- Lee, W. J. and B. T. Zhu. 2005. Mechanisms for the inhibition of DNA methyltransfeases by tea catechins and bioflavonoids. Mol. Pharmacol. 68, 1018-1030 https://doi.org/10.1124/mol.104.008367
- Lee, W. J. and B. T. Zhu. 2006. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 27, 269-277 https://doi.org/10.1093/carcin/bgi206
- Lukas, J., L. Aagaard, M. Strauss and J. Bartek. 1995. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. Cancer Res. 55, 4818-4823
- Mizuno, S. I., T. Chijiwa, T. Okamura, K. Akashi, Y. Fukumaki, Y. Niho and H. Sasaki. 2001. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97, 1172-1179 https://doi.org/10.1182/blood.V97.5.1172
- Momparler, R. L. and V. Bovenzi. 2000. DNA methylation and cancer. J. Cell. Physiol. 183, 145-154 https://doi.org/10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V
- Okano, M., D. W. Bell, D. A. Harber and E. Li. 1999. DNA methyltransfereases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257 https://doi.org/10.1016/S0092-8674(00)81656-6
- Palmisano, W. A., K. K. Divine, G. Saccomanno, F. D. Gilliland, S. B. Baylin, J. G. Herman and S. A. Belinsky. 2000. Predicting lung cancer by detecting aberrant promoter methylation in sputum Cancer Res. 60, 5954-5986
- Paz, M. F., M. F. Fraga, S. Avila, M. Guo, M. Pollan, J. G. Herman and M. A. Esteller. 2003. A systemic profile of DNA methylation in human cancer cell lines. Cancer Res. 63, 1114-1121
- Tate, P. H. and A. P. Bird. 1993. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev. 3, 226-231 https://doi.org/10.1016/0959-437X(93)90027-M
- Yang, C. S., P. Maliakal and X. Meng. 2002. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 42, 25-54 https://doi.org/10.1146/annurev.pharmtox.42.082101.154309
- Zhu, B. T., E. L. Ezell and J. G. Liehr. 1994. Catechol-O-methyltransferase-catalyzed rapid O-methylation of mutagenic flavonoids. Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo. J. Biol. Chem. 269, 292-299
- Zhu, B. T. and J. G. Liehr. 1996. Inhibition of catechol-O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiol-induced tumorigenesis. J. Biol. Chem. 271, 1357-1363 https://doi.org/10.1074/jbc.271.3.1357
- Zhu, B. T., U. K. Patel, M. X. Cai and A. H. Conney. 2000. O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase. Drug Metab. Dispos. 28, 1024-1030
- Zhu, B. T., U. K. Patel, M. X. Cai, A. J. Lee and A. H. Conney. 2001. Rapid conversion of tea catechins to mono-methylated products by rat liver cytosolic catechol-O-methyltransferase. Xenobiotica 31, 879-890 https://doi.org/10.1080/00498250110079798